Indee Labs, a biotechnology company developing a scalable, non-viral intracellular delivery system based on microfluidic vortex shedding (µVS), today announced the United States Patent Office has issued U.S. Patent No. 10,501,716 covering a system for introducing exogenous material to cells with microfluidic vortex shedding.
December 12, 2019
· 2 min read